Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study With Ademetionine (Heptral®) in Subjects With Intrahepatic Cholestasis (IHC) Associated With Alcoholic Liver Disease (ALD)

NCT02200029 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT02200029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02200029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study With Ademetionine (Heptral®) in Subjects With Intrahepatic Cholestasis (IHC) Associated With Alcoholic Liver Disease (ALD)
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2014
Completion date
February 28, 2015
Enrollment
75 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

intrahepatic cholestasis associated with alcoholic liver disease